Aripiprazole Tablet, Orally Disintegrating Breastfeeding

For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Aripiprazole Tablet, Orally Disintegrating and its risk associated with lactation. We will also discuss the usage of Aripiprazole Tablet, Orally Disintegrating and some common side effects associated with Aripiprazole Tablet, Orally Disintegrating.

What is Aripiprazole Tablet, Orally Disintegrating used for?


Aripiprazole orally disintegrating tablets are indicated for the treatment of: Schizophrenia [see CLINICAL STUDIES (14.1)] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.’s ABILIFY® (aripiprazole) product. However, due to Otsuka America Pharmaceutical, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Aripiprazole orally disintegrating tablets are an atypical antipsychotic. The oral formulations are indicated for: Schizophrenia (14.1)

I am currently breastfeeding and I want to know if using Aripiprazole Tablet, Orally Disintegrating is safe for my kid? Does it have any effect on milk production?

Aripiprazole Tablet, Orally Disintegrating low risk for breastfeeding
Aripiprazole Tablet, Orally Disintegrating contains only one active ingredient that is Aripiprazole. We have analyzed the usage of Aripiprazole in breastfeeding and our analysis suggest that Aripiprazole poses Low risk for infant while breastfeeding and hence Aripiprazole Tablet, Orally Disintegrating itself shall be considered Low risk item for breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Aripiprazole is present in human breast milk. Because of the potential for serious adverse reactions in nursing infants from aripiprazole, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Aripiprazole Tablet, Orally Disintegrating Breastfeeding Analsys


Aripiprazole while Breastfeeding

Low Risk

CAS Number: 129722-12-9

ts pharmacokinetic data (low oral bioavailability, large volume of distribution, moderately elevated molecular weight and high plasma protein binding) explains the negligible or zero passage into milk observed (Grover 2015, Nordeng 2014, Watanabe 2011, Lutz 2010, Schlotterbeck 2007). No problems were observed in infants whose mothers were taking it (Nordeng 2014, Tarikh 2014, Lutz 2010). The plasma levels of these infants were undetectable or very low (Watanabe 2011). Its relationship with prolactin is controversial because it lowers prolactin levels and has been used to treat prolactinomas and hyperprolactinemia induced by the use of other antipsychotics (Bakker 2016, Ranjbar 2015, Raghuthaman 2015, Safer 2013, Byerly 2009, Lorenz 2007, Goodnick 2002), but cases of decreased milk production have been reported (Frew 2015, Mendhekar 2006) and hyperprolactinemia triggered by aripiprazole has been reported (Sogawa 2016, Prost 2016, Saraf 2014, Mendhekar 2005, Ruffatti 2005). Due to its slow elimination, it may be worthwhile using other compatible antipsychotics with a shorter half-life, especially during the neonatal period and in case of prematurity (Uguz 2016). Monitor for possible drowsiness in the infant (Hale 2017 p.74).

Aripiprazole Tablet, Orally Disintegrating Breastfeeding Analsys - 2


Aripiprazole while Breastfeeding

CAS Number: 129722-12-9

Limited information indicates that maternal doses of aripiprazole up to 15 mg daily produce low levels in milk, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1] Aripiprazole can lower serum prolactin in a dose-related manner, but cases of gynecomastia and galactorrhea have also been reported.

Is Aripiprazole Tablet, Orally Disintegrating safe while breastfeeding

What should I do if I am breastfeeding mother and I am already exposed to Aripiprazole Tablet, Orally Disintegrating?

Aripiprazole Tablet, Orally Disintegrating is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Aripiprazole Tablet, Orally Disintegrating so you should inform him based on your convenience.


My health care provider has asked me to use Aripiprazole Tablet, Orally Disintegrating, what to do?

Though Aripiprazole Tablet, Orally Disintegrating dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Aripiprazole Tablet, Orally Disintegrating, will my baby need extra monitoring?

Not much monitoring required while using Aripiprazole Tablet, Orally Disintegrating


Who can I talk to if I have questions about usage of Aripiprazole Tablet, Orally Disintegrating in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Aripiprazole Solution
Abilify Maintena | Aripiprazole Kit
Abilify Mycite | Aripiprazole Tablet